[CYCC] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
30-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -6.16%
YoY- -88.80%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -6,110 -5,559 -5,246 -6,491 -5,985 -6,091 -4,165 29.07%
Tax -1,014 -984 -1,138 -1,197 -998 -964 -687 29.60%
NP -5,096 -4,575 -4,108 -5,294 -4,987 -5,127 -3,478 28.97%
Tax Rate - - - - - - - -
Total Cost 5,096 4,575 4,108 5,294 4,987 5,127 3,478 28.97%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.41 -0.45 -0.41 -0.54 -0.53 -0.56 -0.50 -12.38%
EPS Diluted -0.41 -0.45 -0.41 -0.54 -0.53 -0.56 -0.50 -12.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.